Kymera Therapeutics (KYMR) Research & Development: 2019-2025
Historic Research & Development for Kymera Therapeutics (KYMR) over the last 6 years, with Sep 2025 value amounting to $74.1 million.
- Kymera Therapeutics' Research & Development rose 22.65% to $74.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $304.6 million, marking a year-over-year increase of 37.56%. This contributed to the annual value of $240.2 million for FY2024, which is 27.06% up from last year.
- According to the latest figures from Q3 2025, Kymera Therapeutics' Research & Development is $74.1 million, which was down 5.48% from $78.4 million recorded in Q2 2025.
- Over the past 5 years, Kymera Therapeutics' Research & Development peaked at $80.3 million during Q1 2025, and registered a low of $26.0 million during Q1 2021.
- Moreover, its 3-year median value for Research & Development was $59.2 million (2024), whereas its average is $60.2 million.
- Data for Kymera Therapeutics' Research & Development shows a peak YoY spiked of 154.87% (in 2021) over the last 5 years.
- Quarterly analysis of 5 years shows Kymera Therapeutics' Research & Development stood at $37.5 million in 2021, then climbed by 14.93% to $43.1 million in 2022, then grew by 22.81% to $53.0 million in 2023, then spiked by 35.58% to $71.8 million in 2024, then increased by 22.65% to $74.1 million in 2025.
- Its Research & Development was $74.1 million in Q3 2025, compared to $78.4 million in Q2 2025 and $80.3 million in Q1 2025.